Skip to content

A Clinical Study Of Vardhaman Pippali Rasayan and Vidangadi Loha In Anaemia

Randomised Controlled Clinical Trial Of Add-on Effect Of Vardhaman Pippali Rasayana On Vidangadi Loha In Management Of Pandu.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047446
Enrollment
80
Registered
2022-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E611- Iron deficiency

Interventions

None listed

Sponsors

Tilak Ayurved Mahavidyalaya Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)The presence of symptoms of Pandu as described in classical Ayurvedic texts such as Panduta, Dourbalya, Shirshoola, Shwasa, Hridaspandan, Aruchi, Akshi koota shotha, Pindikoudveshthan, Bhrama, Rukshata, Gourava and Shrama. 2)Women of reproductive age group of 15-49 years 3)Patients having history of Hb% 360 µg/dl.

Exclusion criteria

Exclusion criteria: 1)Patients having history of Haemoglobin 2)Patients suffering from haematological disorders such as sickle-cell anaemia and thalassemia are excluded. 3)Patients having history of systemic disorders such as uncontrolled hypertension, uncontrolled diabetes mellitus, AIDS, and cancer. 4)Pregnant females and lactating mothers. 5)Gynaecological diseases like Menorrhagia and Obstetric disorders leading to blood loss 6)Grishma and Sharad Ritu.

Design outcomes

Primary

MeasureTime frame
Improvement in PANDUTA, DOURBALYA, SHIRASHOOLA, SHWAS ,HRIDSPANDAN, ARUCHI, AKSHIKOOTA, SHOTH, PINDIKODWESHTAN, BHRAMA, RUKSHATA, GAURAVA, SHRAMA, Hb% ,RBC, MCV, MCH, MCHC and TIBCTimepoint: baseline,10th day, 21st day

Secondary

MeasureTime frame
to study the adverse effects of Vardhaman Pippali rasayan, if anyTimepoint: 21 days

Countries

India

Contacts

Public ContactDr Abhaychandra S Inamdar

Tilak Ayurved Mahavidyalay, Pune

drasinamdar@yahoo.com9767318431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026